Whole genome sequencing as an investigational device for return of hereditary disease risk and pharmacogenomic results as part of the All of Us Research Program
Eric Venner, Donna Marie Muzny, Joshua D. Smith, Kimberly Walker, Cynthia L. Neben, Christina M. Lockwood, Philip E. Empey, Ginger Metcalf, C. Kachulis, Sana Mian, Anjene Musick, Heidi L. Rehm, Steven M. Harrison, Stacey Gabriel, Richard A. Gibbs, , Niall J. Lennon
The paper describes the process of obtaining an FDA IDE for returning genomic results via WGS in the All of Us Research Program and presents validation results.
Genome Medicine · Mar 28, 2022Peer-reviewedGenetic & Genomic Medicine